Steroids

Subscribe to Selected New Research on Steroids

14366 relevant articles (1035 outcomes, 1170 trials/studies) found for this Bio-Agent

Description: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)

Also Known As:

Catatoxic Steroids; Steroids, Catatoxic

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 59

Steroids: 14366

Bile Acids and Salts: 2880

Ketosteroids: 22

Fluorinated Steroids: 19

BTK 8L preparation: 4

macrostemonoside A: 2

methyl protogracillin: 2

6-deoxocathasterone: 1

(17beta,20R,22E,24R)-1-methyl-19-norergosta-1,3,5,7,9,14,22-heptaene

(17beta,20R,22E,24R)-19-norergosta-1,3,5,7,9,14,22-heptaene

(3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester

11,20,24-trihydroxyecdysone

11,20,26-trihydroxyecdysone

11alpha-O-benzoyl-12beta-O-acetyltenacigenin B

13-ethyl-11-methylenegon-4-en-17-one

13beta-methyl 19-nor-steroid

2-deoxy-20-hydroxyecdysone-22-O-glucopyranoside

22-deoxy-20,21-dihydroxyecdysone

22-hydroxy-25-furost-5-en-12-on-3beta,22,26-triol 26-O-beta-D-glucopyranoside

22E-trien-3beta-benzoate 9(11) 24beta-ethylcholesta-5

23-keto-cladiellin-A

26-(glucopyranosyloxy)-22-methoxy-furost-5-en-3-yl O-apio-D-furanosyl-1-2-O-(6-deoxymannopyranosyl-1-4)glucopyranoside

26-glucopyranosyloxy-2-methoxy-furost-5-en-3-yl O-apio-furanosyl-1-4-O-(rhamnopyranosyl-1-2)glucopyranoside

26-hydroxypinnatasterone

26-O-beta-glucopyranosyl-(25S)-5alpha-furostane-12-one-3beta,22alpha,26-triol-3-O-beta-glucopyranosyl(1-4)-(alpha-rhamnopyranosyl(1-2))-beta-galactopyranoside

26-O-beta-glucopyranosyl-5alpha-furostane-12-one-3beta,22alpha,26-triol-3-O-beta-glucopyranosyl(1-2)-beta-galactopyranoside

26-O-glucopyranosyl-22-methoxy-furostan-3,26-diol 3-O-(glucopyranosyl-1-2-glucopyranoside)

3,3-difluoro-5beta-cholan-24-oic acid

3,6-dimethyl-2,3,3a,4,5,8,9,10,10,11,11,11-dodecahydro-1H-cyclopenta(a)anthracene-3,8-dione

3-hydroxy-22-methoxy-26-glucopyranosyloxy-furostan-2-one-3-O-(O-rhamnopyranosyl-(1-2)-O-(O-arabinopyranosyl-(1-2)-O-(xylopyranosyl-(1-3))-glucopyranosyl-(1-4))galactopyranoside)

3-hydroxy-22-methoxy-26-O-glucopyranosyloxy-furost-25(27)-en-2-one-3-O-(O-rhamnopyranosyl-(1-2)-O-(O-arabinopyranosyl-(1-2)-O-(xylopyranosyl-(1-3))-glucopyranosyl-(1-4))galactopyranoside)

3-hydroxy-3,6-dimethyl-2,3,3,4,5,8,9,10,10,11,11,11-dodecahydro-1H-cyclopenta(a)anthracene-8-one

3-O-beta-D-glucopyranosyl-stigmasta-5,11(12)-diene

3-O-sulfomarthasterone

3-oxo-bisnorchola-1,4-dien-22-oic acid

3-vanilloyloxy-stigmast-5-ene-7-one

3beta-dimethylaminocon-5-enin-18-one

5 alpha-conanin-3 beta-ol

6-deoxocastasterone

6E-hydroximinosteroid

7,14-epoxyazedarachin B

7-hydroxy-4,22-stigmastadien-3-one

9,19-cyclolanosta-24,24-dimethyl-25-en-3-ylhydroxycinnamate

bacosterol-3-O-beta-D-glucopyranoside

balanitesin

balanitoside

bebrycoside

beta-anhydroepidigitoxigenin

caudatin-3-O-beta-D-cymaropyranosyl-(1-4)-beta-D-digitoxopyranoside

caudatin-3-O-beta-D-oleandropyranosyl-(1-4)-beta-D-cymaropyranoside

Experts

1.	Schüle, Cornelius: 4 articles (06/2006 - 03/2003)
2.	Rupprecht, Rainer: 4 articles (06/2006 - 03/2003)
3.	Romeo, Elena: 4 articles (06/2006 - 03/2003)
4.	Butler, C C: 4 articles (01/2006 - 01/2000)
5.	Hill, M: 4 articles (04/2002 - 12/2000)
6.	Chaudry, Irshad H: 3 articles (07/2008 - 01/2004)
7.	Hampl, R: 3 articles (01/2008 - 12/2000)
8.	Le Mellédo, Jean-Michel: 3 articles (08/2007 - 05/2002)
9.	Duiverman, E J: 3 articles (04/2007 - 03/2001)
10.	Marik, Paul E: 3 articles (03/2007 - 10/2002)

Related Diseases

1.	Asthma (Bronchial Asthma) 06/01/2001 - "When the most recent study involving the use of the Saskatchewan databases is considered, it is evident that regular treatment with conventional or low-dose inhaled cortico-steroids results in a significant reduction in fatalities due to asthma. " 06/01/2002 - "Systemic steroids are highly effective for patients with moderate-to-severe asthma exacerbations. " 01/01/2000 - "Inhaled steroids are recognized as the most potent anti-inflammatory medication available, and they are now profiled as the cornerstone in the management of chronic persistent asthma. " 08/01/2000 - "Short-term treatment with oral steroids is very effective in control ling symptoms and improving lung function in asthma but has not been shown unequivocally to reduce bronchial hyperresponsiveness. " 07/01/1999 - "BACKGROUND: Optimal management of chronic, mild-to-moderate asthma with inhaled steroids may include use of the lowest possible doses, as recommended in guidelines, and a reduction in the frequency of daily administration for greater convenience. " Order ALL the reference details at left...
2.	Pain (Aches) 09/01/1986 - "The patient's history and a description of the pain and the corresponding neurological abnormalities present were of value in the selection of patients who were most likely to respond favorably to epidural steroids, whereas laboratory studies were not as useful. " 12/01/1994 - "Best results for the management of pain was observed in patients receiving intralesional steroids, followed by intercostal block and lumbar sympathetic block for abdominal malignancies." 01/01/2006 - "A third trial reported that oral steroids provided a more rapid initial improvement in pain compared to no treatment but negligible differences by five months. " 01/01/1994 - "In the course of treatment there was significant improvement in pain and mobility, in the number of inflamed joints and use of steroids. " 05/27/1988 - "In the course of treatment there was significant improvement in pain and mobility, as well as in the number of inflamed joints, strength of hand-grip (both hands), and use of steroids. " Order ALL the reference details at left...
3.	Crohn Disease (Crohn's Disease) 08/01/1994 - "BACKGROUND: Steroids are highly effective in active Crohn's disease; clinical relapse following steroid withdrawal, however, is frequent. " 01/01/1992 - "Steroids are very useful drugs in the treatment of active Crohn's disease (CD), but clinical relapses after steroid withdrawal may be very high. " 08/01/1997 - "CONCLUSIONS: These data suggest that, in the short term, an oral elemental diet is at least as effective as steroids in inducing remission of mild-moderately active Crohn's disease, but it may be more effective in improving the nutritional status of these patients, probably through a more rapid restoration of normal intestinal permeability." 02/01/1990 - "The present study strongly suggests that elemental diet is superior to steroids for treating active Crohn's disease." 03/01/1996 - "RESULTS: Our meta-analysis indicated that steroids are more effective than defined-formula diets for inducing remission in active Crohn's disease. " Order ALL the reference details at left...
4.	Inflammation 12/01/2004 - "All the adults reported had improved vision and most had resolution of inflammation, with or without topical steroids, over the course of a few months. " 01/01/2007 - "CONCLUSION: There is a certain proportion of asthmatic patients for whom long-term treatment with dry powder type steroids may not be suitable; however, their peripheral airway inflammation improved after switching them to HFA-BDP, suggesting its excellent delivery." 04/01/2003 - "CONCLUSION: Systemic steroid with a slow taper has been the established first-line treatment for idiopathic orbital inflammation, but refractory cases accounted for a significant portion of treatment failures in our study, reflecting the need for a more systematic approach to the study of this multifaceted disease and for therapeutic alternatives to systemic steroids." 08/01/2003 - "RESULTS: Oral steroids alone were insufficient to maintain sustained remission of ocular inflammation. " 07/01/1995 - "In an effort to better characterize this subset of patients with severe RA-associated corneal and/or scleral inflammation and to analyze the efficacy of therapy, we reviewed our experience in the medical and surgical management of 16 tertiary referral cases (25 eyes) unresponsive to aggressive conventional therapy with topical and systemic steroids as well as with systemic nonsteroidal drugs. " Order ALL the reference details at left...
5.	Ulcerative Colitis 09/28/2008 - "Although systemic steroids are highly efficacious in ulcerative colitis (UC), failure to respond to steroids still poses an important challenge to the surgeon and physician alike. " 11/01/1999 - "Despite its intermittent course of activity and remission, the good response to salazopyridine and steroids makes the long-term prognosis of ulcerative colitis favorable. " 07/01/1995 - "Sixty percent (18/30) of severe ulcerative colitis were in remission after mean duration of 9.2 days (range 2-20 days) of intensive intravenous therapy without major side effects of steroids. " 05/01/2008 - "CONCLUSIONS: Intravenous CsA is effective in inducing remission of ulcerative colitis in severe attacks resistant to i.v. steroids. " 10/01/2004 - "In ulcerative colitis, steroids are rarely needed as 5-aminosalicylates are effective in the majority of patients. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cyclophosphamide (Cytoxan)
2.	Cyclosporine (Ciclosporin)
3.	Azathioprine (Imuran)
4.	Anti-Bacterial Agents (Antibiotics)
5.	Immunosuppressive Agents (Immunosuppressants)
6.	Adrenal Cortex Hormones (Corticosteroids)
7.	Hydrocortisone (Cortisol)
8.	Histamine Antagonists (Antihistamines)
9.	Immunoglobulins (Immunoglobulin)
10.	Bronchodilator Agents (Bronchodilators)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Plasma Exchange
3.	Splenectomy
4.	Aftercare (After-Treatment)
5.	Injections

Best Treatments:
Research Summary Report
on Asthma

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 2978 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>